XYL

Xylem Inc

Stock · NYSE

Program summary

FieldValueAs ofSource
Current authorization$3.0bn13-Nov-268-K filed 13-Nov-26
Remaining authorization$1.6bnEST13-Nov-268-K filed 13-Nov-26
Program expiryn/a—
Repurchased last quarter$348m30-Sep-2610-Q filed 27-Oct-26
Has used an ASRNo—

Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.

Programs

Authorized onAuthorizedRemainingExpiresTerms
13-Nov-26$1.5bn$1.5bnESTn/aNew share repurchase program with no expiration date; repurchases may be made through open market purchases or otherwise8-K filed 13-Nov-26
25-Feb-26$1.5bn$105mn/aOn February 25, 2026, our Board of Directors authorized the repurchase of up to $1.5 billion in shares with no expiration date.10-Q filed 27-Oct-26

Open-market repurchases

Repurchased per month, USD (≈ shares × average price)
  1. Jul ’26
  2. Aug ’26
  3. ≈$212m
    Sep ’26
Month endedSharesWithheld & otherAvg price≈ ValueSource
30-Sep-261,980,0002,331$107.14$212m10-Q filed 27-Oct-26
31-Aug-261,117,901—$114.50$128m10-Q filed 27-Oct-26
30-Jul-2670,07143$117.12$8m10-Q filed 27-Oct-26
Filings through 13-Nov-26· checked 18-Nov-26